Carboplatin prodrug conjugated Fe3O4 nanoparticles for magnetically targeted drug delivery in ovarian cancer cells-Reference-Cited by-同舟云学术

Carboplatin prodrug conjugated Fe3O4 nanoparticles for magnetically targeted drug delivery in ovarian cancer cells

Published:2019 Issue:3 Volume:7 Page:433-442
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Song Haiqin¹²³⁴⁵,Quan Feifei⁶⁷⁸,Yu Zhiqiang⁹¹⁰¹¹¹²⁸^ORCID,Zheng Minhua¹²³⁴⁵,Ma Yan⁶⁷⁸,Xiao Haihua¹³¹⁴¹⁵¹⁶¹⁷,Ding Fang¹⁸¹⁹²⁰²¹²²^ORCID

Affiliation:

1. Department of General Surgery

2. Ruijin Hospital

3. Shanghai Jiao Tong University School of Medicine, and Shanghai Minimally Invasive Surgery Center

4. Shanghai

5. P. R. China

6. The First Affiliated Hospital of University of South China

7. Hengyang

8. China

9. School of Pharmaceutical Sciences

10. Guangdong Provincial Key Laboratory of New Drug Screening

11. Southern Medical University

12. Guangzhou

13. Beijing National Laboratory for Molecular Sciences

14. State Key Laboratory of Polymer Physics and Chemistry

15. Institute of Chemistry

16. Chinese Academy of Sciences

17. Beijing 100190

18. Nanshan District Key Lab for Biopolymers and Safety Evaluation

19. Shenzhen Key Laboratory of Polymer Science and Technology

20. Guangdong Research Center for Interfacial Engineering of Functional Materials

21. College of Materials Science and Engineering

22. Shenzhen University

Abstract

The magnetically targeted NPs@carboplatin can act as a drug delivery system and will have great potential in ovarian cancer therapeutic applications.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2019/TB/C8TB02574F

Reference41 articles.

1. The resurgence of platinum-based cancer chemotherapy

2. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance

3. Cancer nanomedicine: progress, challenges and opportunities

4. Gold nanorods for platinum based prodrug delivery

5. Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04

2. Receptor mediated targeting of EGF-conjugated alginate-PAMAM nanoparticles to lung adenocarcinoma: 2D/3D in vitro and in vivo evaluation;International Journal of Biological Macromolecules;2024-03

3. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

4. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer;Molecular Biology Reports;2024-01-13

5. Multifunctional and eco-friendly nanohybrid materials as a green strategy for analytical and bioanalytical applications: Advances, potential and challenges;Microchemical Journal;2023-11